Neutralization assays constitute the definitive means to quantify the functional capacity of antibodies to inhibit SARS-CoV-2 entry into host cells. By assessing how serum or monoclonal antibodies ...
Multiple sublineages of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have dominated the coronavirus disease 2019 pandemic since December 2021. BA.5 is currently ...
Biomedical research faces a ubiquitous and fundamental challenge: Because the goal of the research is to improve human health, the human body is logically the best place to perform experiments.
In a recent study posted to bioRxiv*, researchers evaluated how angiotensin-converting enzyme 2 (ACE2) expression in target cells impacts neutralization. Study: Receptor binding domain (RBD) ...
Shown are neutralizing-antibody titers against virus pseudotyped with spike protein from ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) bearing the D614G mutation, along with ...
Virus neutralizing assays (VNAs) are the gold standard for screening serum for neutralizing antibodies in vitro. These are being used, in many cases, to treat early coronavirus disease 2019 (COVID-19) ...
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533 Vaccine-induced nAbs are detectable at much lower rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results